These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

839 related items for PubMed ID: 18429775

  • 1. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India.
    Kaur I, Dogra S, De D, Kanwar AJ.
    Pediatr Dermatol; 2008; 25(2):184-8. PubMed ID: 18429775
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.
    Ranjan N, Sharma NL, Shanker V, Mahajan VK, Tegta GR.
    J Dermatolog Treat; 2007; 18(5):295-300. PubMed ID: 17852635
    [Abstract] [Full Text] [Related]

  • 3. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
    Puig L.
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
    [Abstract] [Full Text] [Related]

  • 5. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
    Dalaker M, Bonesrønning JH.
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J, Hoffmann M, Wozel G, Ortonne JP, Zheng H, van Hoogstraten H, Reich K.
    Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S, Krishna V, Kanwar AJ.
    Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
    Aydin F, Canturk T, Senturk N, Turanli AY.
    Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
    [Abstract] [Full Text] [Related]

  • 9. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
    Poulalhon N, Begon E, Lebbé C, Lioté F, Lahfa M, Bengoufa D, Morel P, Dubertret L, Bachelez H.
    Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
    [Abstract] [Full Text] [Related]

  • 10. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
    Smith CH, Jackson K, Bashir SJ, Perez A, Chew AL, Powell AM, Wain M, Barker JN.
    Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769
    [Abstract] [Full Text] [Related]

  • 11. Initial experience with routine administration of etanercept in psoriasis.
    de Groot M, Appelman M, Spuls PI, de Rie MA, Bos JD.
    Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
    [Abstract] [Full Text] [Related]

  • 12. Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study.
    Saurat JH, Langley RG, Reich K, Unnebrink K, Sasso EH, Kampman W.
    Br J Dermatol; 2011 Aug; 165(2):399-406. PubMed ID: 21564071
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporin A treatment in severe childhood psoriasis.
    Pereira TM, Vieira AP, Fernandes JC, Sousa-Basto A.
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):651-6. PubMed ID: 16836490
    [Abstract] [Full Text] [Related]

  • 14. Two years of experience with etanercept in recalcitrant psoriasis.
    Ahmad K, Rogers S.
    Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
    [Abstract] [Full Text] [Related]

  • 15. Methotrexate treatment in 13 children with severe plaque psoriasis.
    Collin B, Vani A, Ogboli M, Moss C.
    Clin Exp Dermatol; 2009 Apr; 34(3):295-8. PubMed ID: 19175782
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of infliximab for severe recalcitrant psoriasis after 6 weeks of treatment.
    DE Oliveira JP, Levy A, Morel P, Guibal F.
    J Dermatol; 2008 Sep; 35(9):575-80. PubMed ID: 18837702
    [Abstract] [Full Text] [Related]

  • 17. Weekly vs. daily administration of oral methotrexate (MTX) for generalized plaque psoriasis: a randomized controlled clinical trial.
    Radmanesh M, Rafiei B, Moosavi ZB, Sina N.
    Int J Dermatol; 2011 Oct; 50(10):1291-3. PubMed ID: 21950300
    [Abstract] [Full Text] [Related]

  • 18. Systemic cyclosporine treatment in severe childhood psoriasis: A retrospective chart review.
    Dogra S, Mahajan R, Narang T, Handa S.
    J Dermatolog Treat; 2017 Feb; 28(1):18-20. PubMed ID: 27771982
    [Abstract] [Full Text] [Related]

  • 19. Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a review.
    Kamili QU, Miner A, Hapa A, Menter A.
    J Drugs Dermatol; 2011 May; 10(5):539-44. PubMed ID: 21533302
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate-betamethasone weekly oral pulse in psoriasis.
    Gupta R, Gupta S.
    J Dermatolog Treat; 2007 May; 18(5):291-4. PubMed ID: 17852636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.